chr10-87863171-T-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001126049.2(KLLN):c.-684A>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001126049.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Publications
- Cowden syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- PTEN hamartoma tumor syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- macrocephaly-autism syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- leiomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bannayan-Riley-Ruvalcaba syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lhermitte-Duclos diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Proteus-like syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- glioma susceptibility 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLLN | NM_001126049.2 | c.-684A>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 1 | ENST00000445946.5 | NP_001119521.1 | ||
KLLN | NM_001126049.2 | c.-684A>T | 5_prime_UTR_variant | Exon 1 of 1 | ENST00000445946.5 | NP_001119521.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLLN | ENST00000445946.5 | c.-684A>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 1 | 6 | NM_001126049.2 | ENSP00000392204.2 | |||
KLLN | ENST00000445946.5 | c.-684A>T | 5_prime_UTR_variant | Exon 1 of 1 | 6 | NM_001126049.2 | ENSP00000392204.2 | |||
PTEN | ENST00000688308.1 | c.-17+58T>A | intron_variant | Intron 1 of 9 | ENSP00000508752.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 0
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
The c.-1299 T>A nucleotide substitution has not been published as a pathogenic variant nor as a benign polymorphism to our knowledge. In one study, approximately 9% (9 out of 95) of patients with Cowden syndrome (CS) were identified to have a point mutation in the PTEN core promoter region (Zhou et al., 2003). We cannot predict from the location of c.-1299 T>A what effect it may have on the transcription of the gene or on the resultant protein. Therefore, based on the currently available information, it is unclear whether c.-1299 T>A is a disease-causing or a rare benign variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at